✦ LIBER ✦

Ustekinumab: new option for moderate-to-severe psoriasis

✍ Scribed by Steve Chaplin; Tony Downs

Book ID: 112180444
Publisher: Wiley (John Wiley & Sons)
Year: 2009
Tongue: English
Weight: 82 KB
Volume: 20
Category: Article
ISSN: 0959-6682
DOI: 10.1002/psb.567

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ustekinumab useful for moderate-to-sever

Ustekinumab useful for moderate-to-severe plaque psoriasis

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 195 KB

Comparison of Ustekinumab and Etanercept

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

✍ Griffiths, Christopher E.M.; Strober, Bruce E.; van de Kerkhof, Peter; Ho, Vince 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 411 KB

Spotlight on Ustekinumab in Moderate To

Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis

✍ Croxtall, Jamie D. 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 276 KB

Ustekinumab for Moderate-to-Severe Crohn

Ustekinumab for Moderate-to-Severe Crohn's Disease

✍ Gupta Konijeti, Gauree; Chan, Andrew T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 154 KB

The ACCEPT study: ustekinumab versus eta

The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients

✍ Young, Melodie S; Horn, Elizabeth J; Cather, Jennifer C 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 228 KB

Cost-efficacy of adalimumab, etanercept,

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis

✍ C. Ferrándiz; A. García; A.J. Blasco; P. Lázaro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB